FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21717311000001101: Co-amoxiclav 500mg/125mg tablets 24 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Feb 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72106901000001119 Co-amoxiclav 500mg/125mg tablets 24 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72107001000001115 Co-amoxiclav 500mg/125mg tablets 24 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 500mg/125mg tablets 24 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has VMP Co-amoxiclav 500mg/125mg tablets true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has VMP Co-amoxiclav 500mg/125mg tablets false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has VMP Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets 24 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 625mg tablets (Waymade Healthcare Plc) 24 tablet Is a True Co-amoxiclav 500mg/125mg tablets 24 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start